A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Medical Genetics

• Publication date

  2012-05-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jmedgenet-2012-100852PMID 22652533PMCID PMC5426530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RAD51C is a susceptibility gene for ovarian cancer.

  2011cited by this paper
• BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

  2011cited by this paper
• Functions of the Snf2/Swi2 family Rad54 motor protein in homologous recombination.

  2011cited by this paper
• Germline mutations in RAD51D confer susceptibility to ovarian cancer

  2011cited by this paper
• Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

  2010cited by this paper
• Mutation of the RAD51C gene in a Fanconi anemia–like disorder

  2010cited by this paper
• Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

  2009cited by this paper
• Ten genes for inherited breast cancer.

  2007cited by this paper
• Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer

  2007cited by this paper
• A recurrent mutation in PALB2 in Finnish cancer families

  2007cited by this paper
• Models of genetic susceptibility to breast cancer

  2006cited by this paper
• A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

  2002cited by this paper
• Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

  2001cited by this paper
• Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

  2000cited by this paper
• Borderline ovarian tumors in Finland: epidemiology and familial occurrence.

  1996cited by this paper
• Extracolonic cancer in hereditary nonpolyposis colorectal cancer

  1993cited by this paper

• Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

  2025cites this paper
• What About the Others? Clinical Management of Gynecologic Cancer Risk in Patients With Moderate-Risk Hereditary Cancer Genes (ATM, BRIP1, RAD51C, RAD51D, and PALB2)

  2024influential citation
• Germline RAD51C and RAD51D Mutations in High-Risk Chinese Breast and/or Ovarian Cancer Patients and Families

  2024cites this paper
• Marginal Contribution of Pathogenic RAD51D Germline Variants to Pakistani Early-Onset and Familial Breast/Ovarian Cancer Patients

  2024cites this paper
• Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing

  2024cites this paper
• Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis

  2023cites this paper
• Pathogenic Variant Spectrum in Breast Cancer Risk Genes in Finnish Patients

  2022cites this paper
• Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D

  2022cites this paper
• Rare coding variants in five DNA damage repair genes associate with timing of natural menopause

  2021cites this paper
• Rare coding variants in DNA damage repair genes associated with timing of natural menopause

  2021cites this paper
• The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas

  2021cites this paper
• Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer.

  2021cites this paper
• HRness in Breast and Ovarian Cancers

  2020cites this paper
• BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases

  2020cites this paper
• Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes.

  2019cites this paper
• Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data.

  2019cites this paper
• "Decoding hereditary breast cancer" benefits and questions from multigene panel testing.

  2019cites this paper
• Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma

  2019cites this paper
• Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients

  2019cites this paper
• Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future.

  2019cites this paper
• Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis

  2019cites this paper
• BARD1 is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation

  2019cites this paper
• Aportación de la secuenciación masiva de nueva generación en el diagnóstico del síndrome de cáncer de mama y ovario hereditario mediante el uso de un panel de genes

  2019cites this paper
• Gene‐panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication

  2018cites this paper
• Mutational analysis of RAD51C and RAD51D genes in hereditary breast and ovarian cancer families from Murcia (southeastern Spain).

  2018cites this paper
• Prediction of Colorectal Cancer Driver Genes from Patients’ Genome Data

  2018cites this paper
• Gene panel testing of 5589 BRCA1/2‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer

  2018cites this paper
• Germline breast cancer susceptibility gene mutations and breast cancer outcomes

  2018cites this paper
• Contribution of RAD51D germline mutations in breast and ovarian cancer in Greece

  2018cites this paper
• CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

  2017influential citation
• Digital gene expression profiling analysis of DNA repair pathways in colon cancer stem population of HT29 cells

  2017cites this paper
• Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients

  2017cites this paper
• Inherited Mutations in Women With Ovarian Carcinoma.

  2016cites this paper
• InheritedMutations inWomenWith Ovarian Carcinoma

  2016influential citation
• RNF138 interacts with RAD51D and is required for DNA interstrand crosslink repair and maintaining chromosome integrity.

  2016cites this paper
• RAD51B in Familial Breast Cancer

  2016influential citation
• Next-Generation Sequencing Based Testing for Breast Cancer

  2016cites this paper
• AD51B in Familial Breast Cancer

  2016influential citation
• Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic

  2015cites this paper
• BRCA1, BRCA2, HER2 and RAD51 gene polymorphisms in breast cancer patients of Bangladesh

  2015cites this paper
• Screening of HELQ in breast and ovarian cancer families

  2015cites this paper
• Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers

  2015cites this paper
• Gene-panel sequencing and the prediction of breast-cancer risk.

  2015cites this paper
• RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

  2015cites this paper
• Breast cancer in a RAD51D mutation carrier: case report and review of the literature.

  2015cites this paper
• Mutaciones del gen RAD51 en el cáncer familiar de ovario: revisión de la literatura

  2015cites this paper
• Expression of shelterin and shelterin-associated genes in breast cancer cell lines

  2014cites this paper
• About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants

  2014influential citation
• Analysis of RAD51D in Ovarian Cancer Patients and Families with a History of Ovarian or Breast Cancer

  2013cites this paper
• Hereditary Breast Cancer: The Era of New Susceptibility Genes

  2013cites this paper
• Hereditary breast cancer: ever more pieces to the polygenic puzzle

  2013cites this paper
• Рак яичников в составе наследственных онкологических синдромов (обзор)

  year unknowncites this paper
• RAD 51 , XRCC 3 , and XRCC 2 mutation screening in Finnish breast cancer families

  year unknowncites this paper